AI Verdict
OTLC has stronger fundamentals based on our AI analysis.
OTLC vs QNRX Fundamental Comparison
| Metric | OTLC | QNRX |
|---|---|---|
| Revenue | $70,000.0 | N/A |
| Net Income | $-1.1M | $-15.8M |
| Net Margin | -1,526.0% | N/A |
| ROE | -11.8% | -120.5% |
| ROA | -3.8% | -77.5% |
| Current Ratio | 0.08x | 3.61x |
| Debt/Equity | 0.14x | 0.00x |
| EPS | $0.00 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
OTLC vs QNRX: Frequently Asked Questions
Is OTLC or QNRX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), OTLC has stronger fundamentals. OTLC is rated STRONG SELL (95% confidence) while QNRX is rated STRONG SELL (85% confidence). This is not investment advice.
How does OTLC compare to QNRX fundamentally?
Oncotelic Therapeutics, Inc. has ROE of -11.8% vs Quoin Pharmaceuticals, Ltd.'s -120.5%. Net margins are -1,526.0% vs N/A respectively.
Which stock pays higher dividends, OTLC or QNRX?
OTLC has a dividend yield of N/A or no dividend while QNRX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in OTLC or QNRX for long term?
For long-term investing, consider that OTLC has STRONG SELL rating with 95% confidence, while QNRX has STRONG SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about OTLC vs QNRX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OTLC vs QNRX, the AI consensus favors OTLC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.